Dr. Charles Eugene Eberhart, MD

Dr. Eberhart practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation.

Dr. Eberhart's NPI, 1255367660, was assigned on June 25, 2006. Dr. Eberhart graduated from Heersink School of Medicine - Birmingham in 1988. Dr. Eberhart holds Florida license ME 68261.

Dr. Eberhart's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Dr. Eberhart's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation. Dr. Eberhart is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Eberhart to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eberhart practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Eberhart's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Eberhart is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Eberhart's licenses on file in 3 states: Florida, Alabama and Tennessee.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Eberhart treats.

CMS data shows 1,132 Medicare services from Dr. Eberhart across 16 procedure codes in 2024, for 674 Medicare patients. Medicare paid $123,439 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 674 Medicare patients who saw Dr. Eberhart in 2024. The largest group is 75 to 84, with 288 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Eberhart's median patient age at 69, with 55% women.

In 2024, Dr. Eberhart wrote 1,809 Medicare Part D claims for 494 patients. 88% of them were for generic drugs. CMS names the drug for 1,649 of them, across 29 drugs with 11 or more claims each, at $687,529 in total drug cost. In 2023, CMS named 1,781 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Eberhart for performance year 2024, reported through an alternative payment model (APM). Dr. Eberhart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eberhart as offering telehealth. CMS counts 193 procedures of colonoscopy by Dr. Eberhart, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Eberhart.

CMS Open Payments shows 18 general payments to Dr. Eberhart from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $396.

Dmand AI lists 3 awards for Dr. Eberhart, most recently CMS Stage 1 EHR in 2013.

Dr. Eberhart graduated from Heersink School of Medicine - Birmingham in 1988. Dr. Eberhart is a member of AOA, ACG and AGA.

Dr. Eberhart is in network with 16 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.